LumaSon
Active substance: SULFUR HEXAFLUORIDE, DISTEAROYLPHOSPHATIDYLCHOLINE, DL-, SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL)
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · SULFUR HEXAFLUORIDE 60.7 mg/mg, DISTEAROYLPHOSPHATIDYLCHOLINE, DL- .19 mg/mg, SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL) .19 mg/mg
United StatesActive
Marketing holder: BRACCO DIAGNOSTICS INC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SULFUR HEXAFLUORIDE · 60.7 mg/mg
- DISTEAROYLPHOSPHATIDYLCHOLINE, DL- · .19 mg/mg
- SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL) · .19 mg/mg
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-f936-7776-bc4e-ba4b810f5af7,01a12092-312b-73a0-89de-6f5eb43657fe,01a1209c-c2dc-79e6-a4c0-4387cb9fb48b;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0270-7097
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS, INTRAVESICAL
Sources
- product · openFDA NDC · 0270-7097 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0270-7097 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0270-7097 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0270-7097 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 0270-7097 · Verified 2026-10-09 · open in source